BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2018
View Archived Issues
FDA removes clinical hold and allows initiation of phase I/II study of MRT-5005
Read More
Deinove to acquire Biovertis and clinical-stage antibiotic
Read More
Eisai enters research agreement to develop new treatments for tuberculosis
Read More
FDA grants fast track designation to tenalisib for the treatment of relapsed/refractory CTCL
Read More
Aeglea reports phase I/II data on pegzilarginase in patients with arginase 1 deficiency
Read More
First patient dosed in first-in-human trial of MSB-2311 in advanced solid tumors
Read More
First-in-human data presented for inflammasome modulator SGM-1019
Read More
Gilead's presatovir does not improve outcomes in respiratory syncytial virus infection trial
Read More
CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026
Read More
Bristol-Myers Squibb and Illumina collaborate on companion diagnostics for oncology immunotherapies
Read More
Herantis reports interim safety data from phase I study of Lymfactin
Read More
Bayer initiates phase I study of BAY-2328065 in healthy volunteers
Read More
Rimo studies RiMO-301 with radiation in advanced tumors
Read More
Pfizer presents data on ACC inhibitor PF-05221304
Read More
Eusol initiates phase III study of ES-135 in patients with spinal cord injury
Read More
First phase I data reported for heptatis B virus candidate RO-7049389
Read More
Bayer presents adenosine A2B receptor antagonists and IL-6 release inhibitors
Read More
DGMIF identifies novel WEE1hu inhibitors
Read More
Telix establishes research partnership to study use of its clinical targeting agents with astatine
Read More
Gilead divulges new PI3K inhibitors
Read More
Chugai Pharmaceutical presents new GLP-1 receptor agonists
Read More
Shire agrees to sell oncology business to Servier
Read More
Tiziana in license agreement with BWH for neurodegenerative diseases
Read More
New P2Y6 receptor agonists presented by Tufts University
Read More
Stem-cell based regenerative treatment for Alzheimer's administered to first patients in Japan
Read More